Age-related macular degeneration is an eye disease, that gradually degrades the macula, a part of the retina, which is responsible for central vision. ARMD occurs in one of the two types, 1. Dry ARMD and 2. Wet ARMD. The purpose of this paper is to diagnose the retinal disease ARMD. The extent of the disease spread in the retina can be identified by extracting the features of the retina. Detect...

In the recent years, anti-angiogenic medications have successfully treated other diseases associated with choroidal neovascularization. The anti-angiogenic therapy alone or combined with LASER and/or steroids has been effective in controlling ocular neovascularization, not only restricted to the treatment of typical membranes due to macular degeneration in the wet form. The discovery and subseq...

Copyright: © 2014 Calvo P, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Treat and Extend Versus Treat and Observe Regimens in Wet Agerelated Macular Degeneration Patients Treated with Ranibizumab: 3-...

Background Along with risk factors like smoking, hypertension, atherosclerosis and low choroidal blood flow, genetic susceptibility is a primary contributor to the development and progression of wet age-related macular degeneration (AMD). Vascular endothelial growth factor (VEGF) is a central angiogenic regulator and there is general agreement now that it is one of the most important triggers f...

Due to transparent ocular media, it is relatively easy to observe intraocular tissues such as the vitreous and retina without invasion, and various administration approaches including intravitreal and subretinal injection, or implantation can be applicable. Since the eye-ball is a closed organ, novel therapeutic molecules such as an antisense oligonucleotide for cytomegalovirus retinitis (Fomiv...

The Medical Journal of Australia ISSN: 0025729X 15 March 2010 192 6 346-347 ©The Medical Journal of Australia 2010 www.mja.com.au Lessons from Practice leading to subretinal bleeding, fibrous scar formatio visual loss. Many older patients who have AMD also take me can exacerbate or promote bleeding, such as anti antiplatelet agents. In rare cases, intraocular bleed form of subretinal, suprachor...

Age-related macular degeneration (AMD) is the main cause of visual impairment and blindness in people aged over 65 years in developed countries. Vascular endothelial growth factor (VEGF) is a positive regulator of angiogenesis and its proven role in the pathological neovascularization in wet AMD has provided evidence for the use of anti-VEGF agents as potential therapies. In this study, we revi...

AMD (age-related macular degeneration) is a progressive vision-threatening ocular disease, affecting central region of the retina--the macula--and manifesting in the elderly. AMD is a degenerative disease, and the degeneration affects primarily the retinal pigment epithelial (RPE) cells and secondarily the photoreceptors, leading consequently to disturbances or partial loss of central vision an...

Age-related macular degeneration (AMD) leads to progressive loss of central vision in the elderly. At a cellular level, there is aging of the retinal pigment epithelial (RPE) cells, and accumulation of lipofuscin that interferes with the proper functioning of RPE which eventually leads to apoptosis. Treatment depends on the stage of the disease. Wet AMD which has neovascularization is managed b...